Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | ZIMLAB Zim Laboratories Limited Pharma · Small | LINCOLN Lincoln Pharmaceuticals Limited Pharma · Small | TTKHLTCARE TTK Healthcare Limited Pharma · Small | VALIANTLAB Valiant Laboratories Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 21 | 45 | 48 | 15 |
| Verdict | OVERVALUED | WATCHLIST | FAIR VALUE | OVERVALUED |
| Style | OVERVALUED | Financial Turnaround | FAIR_VALUE | OVERVALUED |
| Piotroski | 6/9 | 8/9 | 5/9 | 4/9 |
| Valuation | 4/30 | 15/30 | 15/30 | 3/30 |
| Growth | 3/25 | 7/25 | 9/25 | 2/25 |
| Quality | 0/20 | 2/20 | 0/20 | 0/20 |
| Balance Sheet | 7/15 | 12/15 | 14/15 | 11/15 |
| Cash Flow | 4/10 | 4/10 | 7/10 | 1/10 |
| Price | ₹113.05 | ₹637.8 | ₹899.35 | ₹72.82 |
| P/E | 133.00 | 14.10 | 18.40 | 72.40 |
| P/B | 1.95 | 1.64 | 1.14 | 1.25 |
| ROE | 1.59% | 12.30% | 6.32% | 2.00% |
| ROCE | 4.76% | 16.30% | 8.04% | 2.54% |
| Debt / Equity | 0.43 | 0.01 | 0.02 | 0.00 |
| FCF Yield | — | 0.64% | 2.45% | — |
| Dividend Y | — | 0.29% | 1.12% | — |
| Altman Z | 3.14 | 8.23 | 5.72 | 5.48 |
| Promoter % | 30.35% | 49.78% | 74.57% | 74.94% |
| Mkt Cap (₹Cr) | 577.00 | 1241.00 | 1267.00 | 402.00 |
| Graham # | ₹36.86 | ₹610.9 | ₹908.37 | ₹36.77 |
| Fair PE | 2.8 | 19.1 | 45.0 | 1.7 |
| MoS % | -3604.3% | +23.9% | +57.0% | -4074.8% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startZIMLAB99
LINCOLN96
TTKHLTCARE59
VALIANTLAB64